Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Digital Prevention Platform for Lifelong Health

Official title: Digital Engagement for Lifelong Prevention and Health Improvement

Run by Istituto per la Ricerca e l'Innovazione Biomedica · NCT07612852 · Data updated 2026-11-12

A digital health platform, DELPHI, will test personalized prevention tips for healthy adults aged 18-65 to see if it improves well-being over 12 months.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorIstituto per la Ricerca e l'Innovazione Biomedica
Academic / other
Locations1 site (Messina)
StatusRecruiting
StartedMay 4, 2026
Main results expectedNovember 30, 2026
Study endsMarch 30, 2027
Registry record updatedMay 29, 2026
Trial IDNCT07612852 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18-65 who own a compatible smartphone and are willing to wear sensors for 12 months.

Probably not a fit

Individuals with active severe chronic diseases, unstable conditions, pregnancy, or cognitive/psychiatric impairments may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

DELPHI uses wearable sensors, artificial intelligence, federated learning, and the Human Digital Twin concept to collect and interpret data from healthy adults. In a multicenter randomized pilot, 200 participants will be assigned to receive the full DELPHI platform with personalized recommendations and continuous feedback or to a passive monitoring control for up to 12 months. The study aims to see if this digital approach can support healthier lifestyle choices and prevention of chronic diseases. Data will be analyzed to tailor content and measure changes in health-related behaviors and outcomes. The trial is conducted across sites in Southern Italy with collaboration among research and hospital partners.

Why it matters

Potential benefit: If successful, participants could receive more personalized guidance to adopt healthier lifestyles and reduce future disease risk.

How similar studies have gone: Previous digital health studies have shown promise with personalized digital interventions, though this exact platform represents a novel integration of HDT and federated learning.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Apparent good general health status, confirmed by medical history and initial self-assessment.
* Ability to understand the study information and provide informed consent.
* Availability and motivation to participate for the entire duration of the study (12 months).
* Access to a smartphone compatible with the DELPHI application.
* Willingness to wear the wearable devices for continuous monitoring of physiological parameters.
* Basic familiarity with mobile applications or willingness to receive training on their use.
* Signed informed consent.

Exclusion Criteria:

* Presence of severe chronic diseases in active phase (e.g., oncological, cardiovascular, or neurological diseases).
* Acute or unstable conditions that could compromise participation in the protocol.
* Current pregnancy.
* Diagnosed major cognitive or psychiatric disorders that hinder understanding of or adherence to the protocol.
* Current use of medications that significantly affect the parameters being monitored (e.g., psychotropic drugs, beta-blockers).
* Simultaneous participation in other clinical studies.
* Logistical difficulties that prevent frequent interaction with the platform (e.g., lack of connection, unwillingness to attend periodic follow-ups).

Where it's running

  • Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)
    Messina, Italy
    Recruiting

Study contacts

  • Principal investigator: Gennaro Tartarisco — Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)
  • Study coordinator: Gennaro Tartarisco
  • Email: gennaro.tartarisco@irib.cnr.it
  • Phone: +393283377046

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.